1JA Clowes,RA Hannon,TA Yap,NR Hoyle,A Blumsohn,R Eastell.Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone . 2002
2Ljunggren 0, Bolinder J, Johansson L, et al. Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mel- litus on metformin[ J]. Diabetes Obes Metab,2012,14 (11 ) :990 - 999.
3Takeuchi Y. Diabetes mellitus and osteoporosis. Therapeutic strate- gy for osteoporosis in patients with diabetes mellitus[ J]. Clin Calci- um,2012,22(9) :1410 - 1415.
4Choi YJ,Yang SO, Shin CS, et al. The importance of morphometric radiographic vertebral assessment for the detection of patients who need pharmacological treatment of osteoporosis among postmenopaus- al diabetic Korean women J]. Osteoporos Int,2012,23 (8) :2099 - 2105.
5Abdulameer SA, Sulaiman SA, Hassali MA,et al. Osteoporosis and type 2 diabetes mellitus:what do we know, and what we can do? [ J]. Patient Prefer Adherence ,2012,6:435 - 448.
